SCHEMBL18908833

SCHEMBL18908833

CCSc1cc(C(F)(F)F)cnc1-c1ccc(OCC(F)(F)C(F)(F)F)nn1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IL1B P01584 1/20 0.40
MAPK1 P28482 1/20 0.33
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19491222 0.90 IL1B (0.43) IL1BMAPK1HPGD
SCHEMBL18908822 0.87 IL1B (0.39) IL1BMAPK1HPGD
SCHEMBL21589881 0.87 IL1B (0.34) IL1B
SCHEMBL20233496 0.87 IL1B (0.34) IL1B
SCHEMBL18908797 0.81 IL1B (0.33) IL1B
SCHEMBL18908821 0.81 IL1B (0.41) IL1BMAPK1HPGD
SCHEMBL18908820 0.79 IL1B (0.33) IL1BMAPK1
SCHEMBL18908832 0.79 ALDH1A1 (0.35) MAPK1
SCHEMBL25899559 0.74 IL1B (0.34) IL1B
SCHEMBL20233436 0.74 IL1B (0.33) IL1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3202761-B1 PYRIDAZINE COMPOUND SUMITOMO CHEMICAL CO (JP) 2022-03-16 EP disclosed
US-9924719-B2 Pyridazine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-27 US disclosed
US-20170295787-A1 PYRIDAZINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-19 US disclosed
EP-3202761-A1 PYRIDAZINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2017-08-09 EP disclosed
WO-2017090655-A1 PEST CONTROL COMPOSITION AND USE THEREOF 住友化学株式会社 2017-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170295787-A1 PYRIDAZINE COMPOUND C5, C3AR1, H1-3 IL1B 2176/4885MAPK1 621/4885HPGD 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.